Ligand Pharmaceuticals
LGND
LGND
227 hedge funds and large institutions have $2.34B invested in Ligand Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 106 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
227
Holders Change
-14
Holders Change %
-5.81%
% of All Funds
4%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.09%
New
36
Increased
56
Reduced
106
Closed
47
Calls
$54.2M
Puts
$108M
Net Calls
-$53.4M
Net Calls Change
+$86.7M
Top Buyers
1 |
BlackRock
New York
|
+$24.5M |
2 |
Millennium Management
New York
|
+$19.7M |
3 |
CC
Chicago Capital
Chicago,
Illinois
|
+$17.7M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.04M |
5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$9.02M |